Approval · Notice of Compliance 7253 · 2005
LIPIDIL EZ: Notice of Compliance 7253
Issued July 18, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7253
- Date
- July 18, 2005
- Company
- Fournier Pharma IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation: nanocrystal
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LIPIDIL EZ | 02269074 | Marketed |
| LIPIDIL EZ | 02269082 | Marketed |
Medicinal ingredients
- FENOFIBRATE 48 MG per TAB
- FENOFIBRATE 145 MG per TAB